For research use only
| Cat No. | ABC-TC3555 |
| Product Type | Immune Cells |
| Cell Type | CD34+ |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human CD34+ bone marrow cells are derived from whole bone marrow and purified using magnetic cell separation.
Human CD34+ Bone Marrow Cells are isolated from whole bone marrow. These cells are obtained from a single donor and exhibit a purity of 95%. Following isolation, the cells are cryopreserved to preserve their functionality. In vitro, these cells typically display a suspension growth pattern. Human CD34+ Bone Marrow Cells are widely used in scientific research, including studies of hematopoiesis, the development of cell-based therapies, and various in vitro functional assays. They serve as a foundational model for understanding stem cell differentiation, lineage commitment, and bone marrow transplantation strategies. To ensure optimal cell viability and experimental reliability, repeated freeze-thaw cycles should be strictly avoided during handling and culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human CD34+ Bone Marrow Cells, CD34 Positive BM Cells, Human BM CD34+ Hematopoietic Stem Cells, CD34+ Hematopoietic Progenitors, BM CD34+ HSCs |
| Species | Human |
| Cat.No | ABC-TC3555 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | CD34+ |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Immune Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human CD34+ Bone Marrow Cells serve as a foundational model for studying hematopoiesis, stem cell differentiation, and bone marrow transplantation. These cells are widely used in evaluating hematologic disease mechanisms and in developing gene therapy or drug screening platforms. Their stem/progenitor properties allow exploration of lineage commitment and immune cell development under defined culture conditions.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).